Publications & Presentations

Vectra Da

Publications & Presentations

Correlation of a Multi-Biomarker Disease Activity Response Assessment to Disease Activity Score 28 (C-Reactive Protein) Response Assessment and OMERACT RAMRIS Scores in a Placebo-Controlled Rheumatoid Arthritis Clinical Trial with Abatacept (ASSET)

Response to Methotrexate Plus Prednisone in CAMERA II Using a Multi-Biomarker Disease Activity (Vectra™ DA) Test and DAS28ESR.

A Multi-Biomarker Disease Activity Score (Vectra™ DA algorithm score) Reflects Clinical Disease Activity and Structural Changes in Rheumatoid Arthritis Patients Treated with Tocilizumab

Correlation of a Multi-Biomarker Disease Activity (Vectra ™ DA) Score with Clinical Disease Activity And Its Components with Radiographic Progression in Rheumatoid Arthritis Patients Treated with Tofacitinib

Utility of Vectra™ DA on Assessment of Rheumatoid Arthritis Disease Activity and Golimumab Response: Results of a Pilot Study From a Phase 3 Trial in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy

Characterization of a multiplex, 12-biomarker test for rheumatoid arthritis

Evaluation of Definitions of Rheumatoid Arthritis Remission by Assessing Radiographic Progression in the Leiden Early Arthritis Cohort

A Multi-Biomarker Disease Activity Score (the Vectra™ DA algorithm score) Reflects Clinical Remission for Rheumatoid Arthritis (RA) in the BeSt Study

A Multi-Biomarker Disease Activity Score (Vectra™ DA algorithm score) Reflects Clinical Disease Activity and Tracks Response in a Japanese Rheumatoid Arthritis Population Treated with Anti-TNF Therapy

A Multi-Biomarker Disease Activity Score (MBDA) Score Measures Rheumatoid Arthritis Disease Activity in Patients Treated with the JAK Inhibitor Tofacitinib

©2018 Crescendo Bioscience, Inc. All rights reserved. Vectra, Crescendo Bioscience, MyRA and the associated logos are trademarks or registered trademarks of Crescendo Bioscience, Inc. in the United States and other jurisdictions.